Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomicsBetty M. Tijms, Pieter Jelle Visser, Johan Gobom et al.|Brain|2020Cited by 221
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 yearsJoel Simrén, Kaj Blennow, Ulf Andréasson et al.|Brain Communications|2022Cited by 187
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's diseaseDeborah O T Alawode, Henrik Zetterberg, Amanda Heslegrave et al.|Journal of Internal Medicine|2021Cited by 105
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington’s disease decades before clinical motor diagnosisRachael I. Scahill, Sarah J. Tabrizi, Mena Farag et al.|Nature Medicine|2025Cited by 53
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkersSophia Weiner, Johan Gobom, Mathias Sauer et al.|Clinical Proteomics|2022Cited by 30